Literature DB >> 3941220

Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography.

S Betocchi, R O Bonow, S L Bacharach, D R Rosing, B J Maron, M V Green.   

Abstract

Left ventricular isovolumic relaxation and the relation between relaxation and filling were studied in 90 patients with hypertrophic cardiomyopathy and 29 control subjects using radionuclide angiography. The isovolumic relaxation period was determined automatically on left ventricular time-activity curves as the interval between minimal volume and onset of rapid filling. In 17 patients, M-mode echocardiography performed simultaneously with radionuclide angiography demonstrated that onset of mitral valve opening correlated well with onset of rapid filling (r = 0.84, p less than 0.001). The isovolumic relaxation period was longer in patients with hypertrophic cardiomyopathy than in control subjects (95 +/- 44 versus 50 +/- 23 ms, p less than 0.01) and was longer in patients without an outflow tract gradient at rest than in patients with a gradient (109 +/- 37 versus 86 +/- 35 ms, p less than 0.05). In these patients without obstruction, a weak linear relation between duration of the isovolumic period and peak filling rate was found (r = 0.48, p less than 0.02). Filling was impaired in patients with hypertrophic cardiomyopathy, as assessed by lower peak filling rate (3.2 +/- 1.2 versus 3.5 +/- 0.5 end-diastolic volume/s, p less than 0.05) and prolonged time to peak filling rate (185 +/- 44 versus 145 +/- 20 ms, p less than 0.01) compared with values in control subjects. The delay in time to peak filling rate was caused primarily by the prolonged isovolumic period, because the interval from onset of rapid filling to peak filling rate was similar in patients with hypertrophic cardiomyopathy and control subjects (87 +/- 31 versus 95 +/- 25 ms, NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3941220     DOI: 10.1016/s0735-1097(86)80262-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging.

Authors:  Daniel B Ennis; Frederick H Epstein; Peter Kellman; Lameh Fananapazir; Elliot R McVeigh; Andrew E Arai
Journal:  Magn Reson Med       Date:  2003-09       Impact factor: 4.668

Review 2.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

3.  Respiratory modulation of cardiac time intervals.

Authors:  P Van Leeuwen; H C Kuemmell
Journal:  Br Heart J       Date:  1987-08

Review 4.  Mechanisms and efficacy of LV pre-excitation for patients with heart failure and supra-normal systolic function.

Authors:  D A Kass
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

5.  Normalised radionuclide measures of left ventricular diastolic function.

Authors:  K J Lee; A E Southee; G J Bautovich; B Freedman; A F McLaughlin; M A Rossleigh; B F Hutton; J G Morris
Journal:  Eur J Nucl Med       Date:  1989

6.  Relation of 99mTc-sestamibi washout with myocardial properties in patients with hypertrophic cardiomyopathy.

Authors:  Satoshi Isobe; Satoru Ohshima; Kazumasa Unno; Hideo Izawa; Katsuhiko Kato; Akiko Noda; Akihiro Hirashiki; Toyoaki Murohara
Journal:  J Nucl Cardiol       Date:  2010-07-16       Impact factor: 5.952

Review 7.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

8.  Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications?

Authors:  Guillermo Romero-Farina; Jaume Candell-Riera; Enrique Galve; Lluís Armadans; Francisca Ramos; Joan Castell; Santiago Aguadé; Juan M Nogales; Jordi Soler-Soler
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

9.  Improvement of relaxation velocity parameters by calcium channel blockers in the aging rabbit myocardium.

Authors:  N C Morcos; J M Gardin; N Tomita; W L Henry
Journal:  Basic Res Cardiol       Date:  1992 Sep-Oct       Impact factor: 17.165

10.  Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.

Authors:  C Schumacher; H Becker; R Conrads; U Schotten; S Pott; M Kellinghaus; M Sigmund; F Schöndube; C Preusse; H D Schulte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.